| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -6,029 | - |
| Accounts payable | - | 109 |
| Stock-based compensation | 415 | 276 |
| Depreciation | 2 | 2 |
| Issuance of warrants for services | 93 | - |
| Loss on disposal of property and equipment | -117 | - |
| Amortization of right-of-use asset | 0 | - |
| Inventory allowances | 230 | - |
| Provision for credit losses | 0 | - |
| Other assets | - | 2 |
| Accounts receivable | -50 | -56 |
| Net loss | - | -3,433 |
| Inventory | -85 | -36 |
| Prepaid expenses and other current assets | 18 | 113 |
| Accounts payable | 340 | - |
| Accrued expenses | 26 | 353 |
| Lease liabilities | 0 | - |
| Other assets | 23 | - |
| Net cash used in operating activities | -4,712 | -2,716 |
| Acquisition of property and equipment | 13 | 3 |
| Acquisition of licensed technology | 543 | 543 |
| Net cash used in investing activities | -556 | -546 |
| Proceeds from issuance of common stock, net of issuance costs | 2,337 | 1,908 |
| Proceeds from issuance of common stock and warrants, net of issuance costs | 0 | - |
| Proceeds from issuance of preferred stock and warrants, net of issuance costs | 4,338 | - |
| Proceeds from issuance of preferred stock and common stock warrants, net of issuance costs | - | 585 |
| Proceeds from warrant exercises | 109 | 109 |
| Offering costs in advance of sale of common stock | 68 | 158 |
| Net cash provided by financing activities | 6,716 | 2,444 |
| Net increase (decrease) in cash and cash equivalents | 1,448 | -818 |
| Cash and cash equivalents at beginning of period | 2,002 | - |
| Cash and cash equivalents at end of period | 3,450 | - |
Tivic Health Systems, Inc. (TIVC)
Tivic Health Systems, Inc. (TIVC)